EU7-52189-59750
3 vaccinations
5 coded responses
36 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 551 / MN
- Registered
- 2022-06-25
- Relationship
- Child or adolescent in my care
- Guardian
- CZ4-19439-41297
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-25
Registered in v-safe
-
2022-06-25
Dose 1 — Pfizer-BioNTech
- 2022-06-25
- 2022-06-26
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-06-30
- 2022-07-01
- 2022-07-02
-
2022-07-09
Survey response — day 14, dose 1, under 3MedDRA: Oropharyngeal pain, Pyrexia — Feeling: Good · Be unable to work or attend schoolFree text: Fever, sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-07-17
-
2022-07-23
Dose 2 — Pfizer-BioNTech
- 2022-07-23
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-07-27
- 2022-07-28
- 2022-07-29
- 2022-07-30
- 2022-08-06
-
2022-08-13
Survey response — day 21, dose 2, under 3MedDRA: Oropharyngeal pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever, sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-08-20
Survey response — day 28, dose 2, under 3MedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: FairFree text: Cold symptoms, runny nose, coughMedDRA releases: 2024-11 · check-in free text available
- 2022-08-27
- 2022-09-03
-
2022-09-23
Dose 3 — Pfizer-BioNTech
- 2022-09-24
- 2022-09-26
- 2022-09-27
- 2022-09-28
- 2022-09-29
- 2022-10-02
- 2022-10-07
- 2022-10-14
-
2022-10-21
Survey response — day 28, dose 3, under 3MedDRA: Nasal congestion, Pyrexia — Feeling: Good · Be unable to work or attend schoolFree text: Fever, nasal congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-10-28
- 2022-11-04
-
2022-12-23
Survey response — 3 months, dose 3, under 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: CovidMedDRA releases: 2024-11 · check-in free text available
- 2023-03-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-25 | Pfizer-BioNTech | No |
| 2 | 2022-07-23 | Pfizer-BioNTech | No |
| 3 | 2022-09-23 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Fever, sore throat
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Fever, sore throat
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Cold symptoms, runny nose, cough
Release 12 (Under 3) — day 28, dose 3, under 3
Symptoms: Fever, nasal congestion
Release 12 (Under 3) — 3 months, dose 3, under 3
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release